EP2748147
Setin 2-alkýl-1-oxó-n-fenýl-3-heteróarýl-1,2,3,4-tetrahýdróísókínólín-4-karboxamíð fyrir mýrarköldumeðferðir
:
EP Einkaleyfi fallið úr gildi:
24.8.2012:
2.8.2017:
12772470.6
:
2.10.2017:
15.10.2017
:
23.8.2032:
23.8.2023
:
SUBSTITUTED 2-ALKYL-1-OXO-N-PHENYL-3-HETEROARYL-1,2,3,4-TETRAHYDROISOQUINOLINE-4-CARBOXAMIDES FOR ANTIMALARIAL THERAPIES
24.8.2012
2.8.2017
2.10.2017
15.10.2017
23.8.2023
:
St. Jude Children's Research Hospital:
262 Danny Thomas Place, 38105, Memphis, TN, US
:
MMV Medicines for Malaria Venture:
20 route de Pré-Bois, ICC, 1215, Geneva, CH
:
Rutgers, The State University Of New Jersey:
08901-1281, New Brunswick, NJ, US
:
GUY, Rodney Kiplin:
Memphis, Tennessee, US
:
ZHU, Fangyi:
Memphis, Tennessee, US
:
GUIGUEMDE, Wendyam Armand:
Memphis, Tennessee, US
:
FLOYD, David:
Pennington, New Jersey, US
:
KNAPP, Spencer:
Skillman, New Jersey, US
:
STEIN, Philip:
Pennington, New Jersey, US
:
CASTRO, Steve:
East Hannover, New Jersey, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201161527594 P:
25.8.2011:
US
:
WO2013027196:
24.8.2012
:
C07D 409/04, A61K 31/4725, A61K 31/506, C07D 417/04, C07D 401/04
: 6
: 12.9.2017
: 23.8.2018
: G. H. Sigurgeirsson
: 7
: 18.7.2018
: 23.8.2019
: G. H. Sigurgeirsson
: 8
: 12.8.2019
: 23.8.2020
: G. H. Sigurgeirsson
: 9
: 11.8.2020
: 23.8.2021
: G.H. Sigurgeirsson ehf.
: 10
: 10.8.2021
: 23.8.2022
: G.H. Sigurgeirsson ehf.
: 11
: 10.8.2022
: 23.8.2023
: G.H. Sigurgeirsson ehf.